FDA Approved: SYMLINPEN — Supplemental Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

The FDA approved a supplemental labeling application for SymlinPen (pramlintide acetate) submitted by AstraZeneca Pharmaceuticals LP. This action updates the pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• SYMLINPEN (PRAMLINTIDE ACETATE)

Snippet

SUPPL AP for SYMLINPEN (PRAMLINTIDE ACETATE)